Group One Trading
ORMP icon

Group One Trading’s Oramed Pharmaceuticals ORMP Stock Holding History

Group One Trading’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,310
Closed -$7.3K – 8462
2025
Q1 		$7.08K Buy
3,310
+3,210
+3,210% +$7.41K ﹤0.01% 6473
2024
Q4 		$242 Hold
100
– – ﹤0.01% 7054
2024
Q3 		$244 Sell
100
-9,088
-99% -$22.2K ﹤0.01% 6444
2024
Q2 		$23.6K Sell
9,188
-9,807
-52% -$23.3K ﹤0.01% 5106
2024
Q1 		$55.5K Buy
18,995
+8,600
+83% +$24K ﹤0.01% 4634
2023
Q4 		$24K Sell
10,395
-100
-1% -$214 ﹤0.01% 5612
2023
Q3 		$27.4K Buy
+10,495
New +$33K ﹤0.01% 5628
2023
Q1 		– Sell
-102,067
Closed -$324K – 7737
2022
Q4 		$1.23M Buy
102,067
+62,910
+161% +$489K ﹤0.01% 2242
2022
Q3 		$254K Buy
39,157
+31,131
+388% +$252K ﹤0.01% 3913
2022
Q2 		$37K Buy
+8,026
New +$42.9K ﹤0.01% 5815
2022
Q1 		– Sell
-5,655
Closed -$57.9K – 8493
2021
Q4 		$81K Sell
5,655
-2,819
-33% -$58.9K ﹤0.01% 5914
2021
Q3 		$186K Buy
8,474
+5,531
+188% +$94.2K ﹤0.01% 5252
2021
Q2 		$39K Buy
+2,943
New +$33.7K ﹤0.01% 6778
2020
Q4 		– Sell
-355
Closed -$1.16K – 6857
2020
Q3 		$1K Buy
+355
New +$1.24K ﹤0.01% 5935
2019
Q1 		– Sell
-16,900
Closed -$51K – 5214
2018
Q4 		$51K Hold
16,900
– – ﹤0.01% 3551
2018
Q3 		$82K Buy
+16,900
New +$87.8K ﹤0.01% 3661
2018
Q1 		– Sell
-11,477
Closed -$88.6K – 5186
2017
Q4 		$103K Buy
11,477
+3,872
+51% +$37K ﹤0.01% 3339
2017
Q3 		$75K Buy
7,605
+5,605
+280% +$48.3K ﹤0.01% 3407
2017
Q2 		$16K Hold
2,000
– – ﹤0.01% 4036
2017
Q1 		$12K Sell
2,000
-3,000
-60% -$18.7K ﹤0.01% 4070
2016
Q4 		$31K Buy
+5,000
New +$32.6K ﹤0.01% 3516
2016
Q2 		– Sell
-10,030
Closed -$85.4K – 4848
2016
Q1 		$67K Sell
10,030
-7,798
-44% -$52.2K ﹤0.01% 3097
2015
Q4 		$152K Buy
+17,828
New +$135K ﹤0.01% 2690
2015
Q3 		– Sell
-719
Closed -$4K – 5097
2015
Q2 		$4K Sell
719
-2,072
-74% -$14.2K ﹤0.01% 4555
2015
Q1 		$18K Buy
2,791
+1,195
+75% +$5.77K ﹤0.01% 3937
2014
Q4 		$7K Sell
1,596
-2,500
-61% -$16.4K ﹤0.01% 4357
2014
Q3 		$33K Buy
4,096
+1,546
+61% +$13.7K ﹤0.01% 3814
2014
Q2 		$25K Sell
2,550
-541
-18% -$5.53K ﹤0.01% 4012
2014
Q1 		$36K Buy
+3,091
New +$52.2K ﹤0.01% 3879

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading's ORMP Position: Q2 2025 in Review

Group One Trading sold out of Oramed Pharmaceuticals (ORMP) in Q2 2025, closing a stake of 3,310 shares — an estimated $7.3K sold.

Group One Trading first reported a position in ORMP in Q1 2014 and held it in 29 quarters. The position peaked at $1.23M in Q4 2022. 47 funds tracked by Wall St. Rank hold ORMP as of Q2 2025.

  • Group One Trading reported no remaining Oramed Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 3,310 Oramed Pharmaceuticals shares in Q2 2025, an estimated $7.3K.
  • Group One Trading first reported a position in Oramed Pharmaceuticals in Q1 2014 and held it in 29 quarters.
  • Group One Trading's Oramed Pharmaceuticals position peaked at $1.23M in Q4 2022.
  • 47 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.